ABBV FY 2011 Earnings Report — AbbVie Inc. Revenue & Financial Results | Market Cap Arena

AbbVie Inc.ABBV

FY 2011 Earnings

Reported December 31, 2011

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2011	Prior Q	FY 2010	QoQ Change	YoY Change
Revenue	$17.4B	—	$15.6B	—	11.5%
Op. Income	$3.6B	—	$4.7B	—	-23.3%
Gross Margin	73.4%	—	72.5%	—	0.9pp
Net Margin	19.7%	—	26.7%	—	-7.0pp
EPS (Diluted)	$2.11	—	$2.57	—	-17.9%
Free Cash Flow	$5.9B	—	$4.5B	—	30.1%

Revenue Flow

Item	Amount
REVENUE	$17.4B
Cost of Revenue	$4.6B
GROSS PROFIT	$12.8B
R&D Expenses	$3.3B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$5.9B
Other Expenses	$0
Operating Expenses	$9.2B
Cost & Expenses	$13.8B
OPERATING INCOME	$3.6B
Interest Income	$20M
Interest Expense	$0
Other Income/Expenses	$48M
INCOME BEFORE TAX	$3.7B
Income Tax Expense	$235M
Net Income from Continuing Ops	$3.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$3.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$3.4B
D&A	$1.3B
EBIT	$3.7B
EBITDA	$4.9B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$17.4B
Cost of Revenue	$4.6B
GROSS PROFIT	$12.8B
R&D Expenses	$3.3B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$5.9B
Other Expenses	$0
Operating Expenses	$9.2B
Cost & Expenses	$13.8B
OPERATING INCOME	$3.6B
Interest Income	$20M
Interest Expense	$0
Other Income/Expenses	$48M
INCOME BEFORE TAX	$3.7B
Income Tax Expense	$235M
Net Income from Continuing Ops	$3.4B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$3.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$3.4B
D&A	$1.3B
EBIT	$3.7B
EBITDA	$4.9B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$3.4B
Depreciation & Amortization	$1.3B
Stock-Based Compensation	$163M
Deferred Income Tax	$0
Other Non-Cash Items	$673M
Change in Working Capital	$706M
OPERATING CASH FLOW	$6.2B
Capital Expenditure	-$356M
Acquisitions (Net)	-$273M
Purchases of Investments	-$1.9B
Sales/Maturities of Investments	$1.3B
Other Investing Activities	$1.9B
NET CASH FROM INVESTING	$554M
Net Debt Issuance	-$21M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	-$6.8B
NET CASH FROM FINANCING	-$6.8B
FREE CASH FLOW	$5.9B
Net Change in Cash	$18M

Balance Sheet

Item	Amount
Cash & Equivalents	$27M
Short-Term Investments	$626M
Net Receivables	$3.8B
Inventory	$872M
Other Current Assets	$1.5B
TOTAL CURRENT ASSETS	$7.4B
PP&E (Net)	$2.1B
Goodwill	$6.1B
Intangible Assets	$2.9B
Long-Term Investments	$229M
Tax Assets	$920M
Other Non-Current Assets	-$136M
TOTAL NON-CURRENT ASSETS	$12.2B
TOTAL ASSETS	$19.5B
Account Payables	$417M
Short-Term Debt	$16M
Deferred Revenue	$0
Other Current Liabilities	$0
TOTAL CURRENT LIABILITIES	$5.9B
Long-Term Debt	$32M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$490M
Other Non-Current Liabilities	$1.0B
TOTAL NON-CURRENT LIABILITIES	$1.7B
TOTAL LIABILITIES	$7.6B
Common Stock	$12.0B
Additional Paid-In Capital	$0
Retained Earnings	$0
Treasury Stock	$0
Accum. Other Comp. Income	-$25M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$11.9B
Minority Interest	$0
TOTAL EQUITY	$11.9B
TOTAL LIABILITIES & EQUITY	$19.5B
Total Debt	$0
Net Debt	-$27M